Drug approvals

FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

What is ORSERDU prescribed for?   For treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy What is the name of the drug and what does it do?  ORSERDU (generic name: elacestrant), pronounced...

FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

What is Sohonos prescribed for?   Sohonos is prescribed to reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva. What is the name of the drug and what does it do? Sohonos, pronounced so-ho-nos, (generic name:...

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

What is Elrexfio prescribed for?   Elrexfio is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Elrexfio, pronounced el-reks-fe-o, (generic name: elranatamab-bcmm). It is a prescription medication approved for...

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

What is Talvey prescribed for?   Talvey is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Talvey, pronounced tal vay, (generic name: talquetamab-tgvs). It is a prescription medication approved to treat adults...

FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

What is XDEMVY prescribed for?   XDEMVY is prescribed to treat a parasitic infection of the eye (Demodex blepharitis) that can  especially affect the eyelids. What is the name of the drug and what does it do? XDEMVY, pronounced X-DEM-VEE, (generic name: lotilaner)  is a prescription medication approved for the treatment of Demodex blepharitis, a...